Worrich Scott, Schuler Gregg, Janicki Piotr K
Department of Anesthesiology, Pennsylvania State University College of Medicine, Milton S. Hershey Medical Center, Hershey, Pennsylvania 17033, USA.
Pain Med. 2007 Jan-Feb;8(1):41-7. doi: 10.1111/j.1526-4637.2007.00144.x.
Transdermal fentanyl is a commonly used analgesic for the treatment of severe chronic pain. Recent investigations have shown the presence of mu-opioid receptors in the skin and opioid analgesic efficacy with alternative routes of administration of narcotics. This placebo-controlled, double-blind prospective study assessed whether transdermal fentanyl administration produces local peripheral opioid analgesia at the site of application.
Baseline pain threshold and supra-threshold pain intensity assessments were measured using Quantitative Sensory Testing in 12 healthy volunteers. Placebo and fentanyl containing patches (Duragesic, 25 microg/h) were applied to opposite forearms for 2 h. After patch removal, pain threshold, supra-threshold pain response, and the area of secondary hyperalgesia were evaluated for both forearms.
No statistically significant differences in pain threshold, supra-threshold pain intensity, or area of hyperalgesia in fentanyl- versus placebo-treated forearms were detected in the study subjects.
These results suggest that the application of transdermal fentanyl patch for a period of 2 h does not produce local peripheral opioid analgesia at the site of patch application.
透皮芬太尼是治疗重度慢性疼痛常用的一种镇痛药。近期研究表明,皮肤中存在μ-阿片受体,且通过其他麻醉给药途径具有阿片类镇痛效果。这项安慰剂对照、双盲前瞻性研究评估了透皮给予芬太尼是否会在用药部位产生局部外周阿片类镇痛作用。
采用定量感觉测试法对12名健康志愿者的基线疼痛阈值和阈上疼痛强度进行评估。将安慰剂贴片和含芬太尼的贴片(多瑞吉,25微克/小时)分别贴于双侧前臂,持续2小时。去除贴片后,对双侧前臂的疼痛阈值、阈上疼痛反应及继发性痛觉过敏区域进行评估。
在研究对象中,未检测到芬太尼治疗组和安慰剂治疗组前臂在疼痛阈值、阈上疼痛强度或痛觉过敏区域方面存在统计学显著差异。
这些结果表明,应用透皮芬太尼贴片2小时不会在贴片应用部位产生局部外周阿片类镇痛作用。